Resurgence of Plasmodium vivax malaria in French Guiana (2023-2024): a multifactorial crisis in the Amazonian region-response to Salazar et al

Affiliations

Loïc Epelboin et al. Lancet Reg Health Am. 2025.

. 2025 Apr 29:45:101074.

doi: 10.1016/j.lana.2025.101074. eCollection 2025 May.

No abstract available

Conflict of interest statement

None.

1. Dahuron L., Musset L., Tréhard H., et al. Malaria control in French Guiana: what are the challenges in this last endemic French territory in 2024? Med Trop Sante Int. 2025;5(1) doi: 10.48327/mtsi.v5i1.2025.536. - DOI - PMC - PubMed
1. Carvalho L., Succo T. Bulletin de Santé publique (BSP) Paludisme Edition Guyane; 2024. Evolution de la situation épidémiologique du paludisme en Guyane au premier trimestre 2024; pp. 11–13.
1. Dia A., Blanc P.-A., Jaffrennou A., et al. Bulletin de Santé publique (BSP) Paludisme Edition Guyane; 2024. Recrudescence du paludisme dans les Forces armées de Guyane en 2023: à propos de 2 clusters survenus dans le cadre de missions de la lutte contre l'orpaillage illégal; pp. 14–16.
1. Douine M., Lambert Y., Galindo M.S., et al. Self-diagnosis and self-treatment of malaria in hard-to-reach and mobile populations of the Amazon: results of Malakit, an international multicentric intervention research project. Lancet Reg Health Am. 2021;4 - PMC - PubMed
1. Sanna A., Suárez-Mutis M., Lambert Y., et al. Cooperation for malaria control and elimination in the Guiana Shield. Lancet Glob Health. 2024;12(5):e875–e881. - PubMed